Why Cash-Pay Patients Disappear From Claims Data
Cash prescriptions bought through drugmaker direct-to-patient programs often leave no insurance claim. Here is why, and where to measure them instead.
Browse practical guidance on privacy-safe healthcare advertising, analytics, patient acquisition, and marketing compliance.
Cash prescriptions bought through drugmaker direct-to-patient programs often leave no insurance claim. Here is why, and where to measure them instead.
How a drugmaker computes cost per patient start and cost per paid fill for a direct-to-patient program, by channel, campaign and partner.
What a drugmaker's direct-to-patient program can send to Meta and Google under their health data rules, and what the FTC's Hims and Hers case alleges.
Twelve questions to ask a direct-to-patient measurement vendor about partner events, aggregate reports, privacy terms and what reaches ad platforms.
How telehealth and pharmacy partners in a drugmaker's direct-to-patient program can report paid fills and refills by campaign, in aggregate, without names.
How a drugmaker can measure a direct-to-patient program from ad to paid fill, with partners sending step events and results reported by campaign.
What HIPAA expert determination requires, why data a recipient already holds changes re-identification risk, and what to ask before data is shared.
Measure a drugmaker direct-to-patient program from ad to paid fill: define the funnel, agree partner events, check match rate, then costs and refills.
What pharma direct-to-patient programs are, which drugmakers run them, how TrumpRx and the OIG bulletin fit in, and what each partner does.
The telehealth partner metrics a drugmaker direct-to-patient program should read: paid-fill rate, time to fill, month-3 and month-6 refills, in aggregate.
What Veeva Crossix measures, in Veeva's own words, and the questions a brand team should ask about cash-pay fills in a direct-to-patient program.
Is Improvado HIPAA compliant? Improvado offers a BAA and says no BAA, no PHI. What that means for healthcare marketing data, checked Nov 20, 2026.
Piwik PRO vs Matomo for healthcare: which one signs a BAA, where your data is hosted, and what each means for clinics running ads. Checked Nov 20, 2026.
Freshpaint vs Segment for healthcare: who signs a BAA, on which plan, and how each handles ad conversions. Vendor quotes checked November 20, 2026.
LegitScript vs NABP for health ads: what Google, Meta and Microsoft require, what each program involves, and which fits a telehealth site.
Google Ads telemedicine certification now accepts LegitScript or NABP. What changed in November 2026, who needs it and how to apply.
Telehealth ads for the Wegovy pill follow prescription drug rules: Meta authorization, Google certification, 18+ targeting. What each platform requires.
Data integration tools with a BAA: what Improvado, Fivetran, Hevo, RudderStack and Twilio Segment say about BAAs, in their own words.
Marketing analytics MCP servers let Claude and ChatGPT query your data. Which servers exist, what each returns, and what a healthcare team should allow.
HIPAA compliance for CRM starts before patient data goes in: the BAA and plan, HIPAA settings, access and audit logs, data flows and ad reporting.
Are tracking pixels illegal on health websites? What HHS, the FTC and Washington State say, the 2024 court ruling, and how to check your own site.
Telehealth marketing without pixels: measure Meta and Google ads server-side, credit intake, booking and prescription steps, and meet telehealth ad rules.
Link tracking tools for healthcare marketers: click IDs, UTM tags and booking handoffs, and how to keep patient details out of tracked URLs.
ChatGPT for Healthcare is OpenAI's HIPAA eligible workspace for health organizations. What its BAA covers, what it leaves out, and what marketers can use.